NUVB

Nuvation Bio Inc

Price

$5.27

return (12m)

39.79%

p/e

16.38

p/bv

7.24

DIVIDEND YIELD

0.00%

NUVB price

Nuvation Bio Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NUVB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-22.16%

3 months

-5.98%

1 year

39.79%

2 years

118.67%

5 years

-47.46%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NUVB

Valuation

P/E

16.38

Sector 7.50

Industry 7.50

P/BV

7.24

Sector 1.77

Industry 1.77

P/Revenue (PSR)

10.82

Sector 1.72

Industry 1.72

EV/EBITDA

-25.31

Sector -842.79

Industry -842.79

EV/EBIT

-25.56

Sector -1,519.48

Industry -1,519.48

P/EBITDA

-17.10

Sector -14.40

Industry -14.40

P/EBIT

-17.21

Sector -12.63

Industry -12.63

P/Total Assets

2.47

Sector 0.83

Industry 0.83

P/Net Current Assets

7.80

Sector -1.96

Industry -1.96

P/Working Capital

2.87

Sector -4,656.37

Industry -4,656.37

EPS

0.32

Sector 0.70

Industry 0.70

BVPS

0.73

Sector 9.63

Industry 9.63

Efficiency

Gross Margin

93.94%

Sector 35.53%

Industry 35.53%

EBITDA Margin

-176.98%

Sector -7,056,892.18%

Industry -7,056,892.18%

EBIT Margin

-175.29%

Sector -159.46%

Industry -159.46%

Operating Margin

-81.00%

Sector 4.35%

Industry 4.35%

Net Profit Margins

66.06%

Sector 2.37%

Industry 2.37%

Asset Turnover

0.04

Sector 0.11

Industry 0.11

Profitability

ROE

44.21%

Sector 2.14%

Industry 2.14%

ROA

15.08%

Sector -0.82%

Industry -0.82%

ROIC

Sector -120.08%

Industry -120.08%

Dividends

Dividend yield

0.00%

Sector 0.53%

Industry 0.53%

Payout

0.00%

Sector 10.02%

Industry 10.02%

Debt

Current Ratio

8.37

Sector 1.47

Industry 1.47

Net Debt / EBITDA

7.46

Sector -20.49

Industry -20.49

Net Debt / EBIT

7.53

Sector -168,192,801.50

Industry -168,192,801.50

Net Debt / Equity

-1.65

Sector -0.78

Industry -0.78

Gross Debt / Equity

0.96

Sector -0.51

Industry -0.51

Equity/Assets

0.34

Sector 0.43

Industry 0.43

Liabilities/Assets

0.66

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals NUVB

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Nuvation Bio Inc ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$5.27

Fair Value

$2.29

Upside

-56.50%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

NUVB - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Nuvation Bio Inc

Nuvation Bio Inc

Average Investor10 user rating

4.0 (1 people)

United States

8 years

Founded: 2018

2021

Time since IPO - 5 years

298

Employees

Nuvation Bio Inc (United States) is listed on the Nasdaq and has a market capitalization of $1.84 billion, with shareholders equity totaling $253.86 million.

The company employs approximately 298 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Nuvation Bio Inc reported $169.90 million in revenue, generating net income of $112.24 million.

Key financial metrics include a P/E ratio of 16.38, a price-to-book (P/B) ratio of 7.24, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NUVB.

Market cap

$1.84 billion

Net worth

$253.86 million

$253,864,000.00

Assets

$744.50 million

$744,503,000.00

Total Shares Outstanding

348.77 million

348,770,000

Average Daily Trading Volume

$5.98 million

$5,983,066.00

Sector

Others

Industry

Others

NUVB

NUVB revenue and profits

Financial Results NUVB

DRAG THE FRAME TO SEE MORE DATA

NUVB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$368.07 4,90% (12M)

P/E

23.51

2.46%

ROE

13.51%

P/BV

3.18

SHEL - Shell PLC ADR

$95.74 35,65% (12M)

P/E

10.30

3.16%

ROE

14.29%

P/BV

1.47

STLA - Stellantis NV

$4.37 --59,26% (12M)

P/E

-0.50

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$307.21 2,24% (12M)

P/E

22.61

0.78%

ROE

81.03%

P/BV

18.32

ALIZY - Allianz SE ADR

$46.75 --19,31% (12M)

P/E

12.88

2.91%

ROE

17.89%

P/BV

2.30

TTE - TotalEnergies SE ADR

$84.50 48,84% (12M)

P/E

6.86

4.78%

ROE

21.42%

P/BV

1.47

NSRGY - Nestle SA ADR

$90.02 0,79% (12M)

P/E

10.81

4.45%

ROE

58.05%

P/BV

6.27

ELV - Elevance Health Inc

$386.86 12,56% (12M)

P/E

19.87

1.71%

ROE

9.84%

P/BV

1.96